Sanofi (SANp)
Euronext Paris • Healthcare
February 27, 2026 at 16:30 UTC
Sanofi is a healthcare company that discovers, manufactures, and supplies medicines and vaccines used in clinical practice. Clinical programs target evidence that can be translated into labeling, and medical information supports safe use after approval. Plants operate to validated procedures, and logistics are planned so pharmacies, hospitals, and clinics receive steady supply. Regional teams handle access and pharmacovigilance under local rules while global functions maintain shared standards. Reporting sits inside the healthcare sector with a focus on operating facts rather than narrative goals. The company describes its role as maintaining continuity for health systems while adding new options through measured change. The stance is process first, with patient safety and data integrity kept at the center of decisions.
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Sanofi's Technical Indicators Summary
SANp is currently exhibiting a bearish trend, with the price trading below all major moving averages, including the 200-day EMA near 88, signaling sustained downward pressure. Momentum indicators reinforce this view, as the RSI remains low near 33 and the MACD level is negative, reflecting weak buying interest. The ADX value around 26 suggests a moderately strong trend, while the volume-based OBV confirms selling dominance. Although volatility measured by ATR is stable and the price sits just below the VWAP and pivot levels, these do not offset the prevailing weakness. Overall, the technical landscape points to a persistent bearish environment for SANp.
| Indicator | Value |
|---|---|
RSI (14) | 33.34 |
Stochastic %K (14, 3, 3) | 4.01 |
CCI (20) | -299.73 |
WPR (14) | -100.00 |
Momentum (10) | -4.82 |
MFI | 44.36 |
MACD Level (12, 26) | -1.09 |
Bollinger Bands | $78.78 - $84.82 |
ATR (14) | $1.70 (2.19%) |
ADX (14) | 25.88 |
OBV | 16,932,512 |
VWAP | $78.13 |
Classic Pivot Point | $79.35 |
Fibonacci Pivot Point | $79.35 |
Simple Moving Averages | $81.44 - $85.40(5 indicators) |
Exponential Moving Averages | $80.70 - $87.88(5 indicators) |
Get premium market insights delivered directly to your inbox.
By the end of trading, SANp had absorbed the small 1.372% gap, settling at 81.99. By the end of trading, the sector had posted a modest gain of 0.66%, offering a gentle tailwind. SANp drifts on limited stock-specific headlines as a modest sector backdrop provides a gentle tailwind.
Price Change
from €80.88 close
+€1.11
Trading Volume
Below avg (2.2M)
946.1K
vs S&P 500 Today
Outperforming Market
+1.64%
52-Week Position
Lower range
16.8%
Updated: February 27, 2026 at 16:06 UTC
Azoria ETFs shut, Novartis India stake sold, tariff shock
February 20, 2026